|
1
|
Kanzawa T, Germano IM, Komata T, Ito H,
Kondo Y and Kondo S: Role of autophagy in temozolomide-induced
cytotoxicity for malignant glioma cells. Cell Death Differ.
11:448–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohgaki H and Kleihues P: The definition of
primary and secondary glioblastoma. Clin Cancer Res. 19:764–772.
2013. View Article : Google Scholar
|
|
5
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis-Dusenbery BN and Hata A: MicroRNA in
cancer: The involvement of aberrant microRNA biogenesis regulatory
pathways. Genes Cancer. 1:1100–1114. 2010. View Article : Google Scholar
|
|
9
|
He J, Deng Y, Yang G and Xie W:
MicroRNA-203 down-regulation is associated with unfavorable
prognosis in human glioma. J Surg Oncol. 108:121–125. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He HC, Han ZD, Dai QS, Ling XH, Fu X, Lin
ZY, Deng YH, Qin GQ, Cai C, Chen JH, et al: Global analysis of the
differentially expressed miRNAs of prostate cancer in Chinese
patients. BMC Genomics. 14:7572013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diosdado B, van de Wiel MA, Terhaar Sive
Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B and Meijer
GA: MiR-17-92 cluster is associated with 13q gain and c-myc
expression during colorectal adenoma to adenocarcinoma progression.
Br J Cancer. 101:707–714. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Xu J, Chen H, Bai J, Li S, Zhao Z,
Shao T, Jiang T, Ren H, Kang C, et al: Comprehensive analysis of
the functional microRNA-mRNA regulatory network identifies miRNA
signatures associated with glioma malignant progression. Nucleic
Acids Res. 41:e2032013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu
P, Song Z, Qian C, Chen Y, Yang S, et al: miR-92b controls glioma
proliferation and invasion through regulating Wnt/beta-catenin
signaling via Nemo-like kinase. Neurooncol. 15:578–588. 2013.
|
|
16
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kruse JP and Gu W: Modes of p53
regulation. Cell. 137:609–622. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Farnebo M, Bykov VJ and Wiman KG: The p53
tumor suppressor: A master regulator of diverse cellular processes
and therapeutic target in cancer. Biochem Biophys Res Commun.
396:85–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gaur AB, Holbeck SL, Colburn NH and Israel
MA: Down-regulation of Pdcd4 by mir-21 facilitates glioblastoma
proliferation in vivo. Neurooncol. 13:580–590. 2011.
|
|
21
|
Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ,
Jeong JA, Jo SH, Kim TH, Min HS, Chae JS, et al: Downregulation of
Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene.
30:2433–2442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han L, Yue X, Zhou X, Lan FM, You G, Zhang
W, Zhang KL, Zhang CZ, Cheng JQ, Yu SZ, et al: MicroRNA-21
expression is regulated by β-catenin/STAT3 pathway and promotes
glioma cell invasion by direct targeting RECK. CNS Neurosci Ther.
18:573–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen SM, Chen HC, Chen SJ, Huang CY, Chen
PY, Wu TW, Feng LY, Tsai HC, Lui TN, Hsueh C, et al: MicroRNA-495
inhibits proliferation of glioblastoma multiforme cells by
down-regulating cyclin-dependent kinase 6. World J Surg Oncol.
11:872013. View Article : Google Scholar
|
|
24
|
Wick W, Naumann U and Weller M:
Transforming growth factor-beta: A molecular target for the future
therapy of glioblastoma. Curr Pharm Des. 12:341–349. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ventura A, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone
JR, et al: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kan T, Sato F, Ito T, Matsumura N, David
S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, et al: The
miR-106b-25 polycistron, activated by genomic amplification,
functions as an oncogene by suppressing p21 and Bim.
Gastroenterology. 136:1689–1700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ivanovska I, Ball AS, Diaz RL, Magnus JF,
Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson
AL, et al: MicroRNAs in the miR-106b family regulate p21/CDKN1A and
promote cell cycle progression. Mol Cell Biol. 28:2167–2174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu F, Gong J, Huang W, Wang Z, Wang M,
Yang J, Wu C, Wu Z and Han B: MicroRNA-106b-5p boosts glioma
tumorigensis by targeting multiple tumor suppressor genes.
Oncogene. 33:4813–4822. 2014. View Article : Google Scholar
|
|
29
|
Fang L, Deng Z, Shatseva T, Yang J, Peng
C, Du WW, Yee AJ, Ang LC, He C, Shan SW, et al: MicroRNA miR-93
promotes tumor growth and angiogenesis by targeting integrin-β8.
Oncogene. 30:806–821. 2011. View Article : Google Scholar
|
